Want to see JP:7707 full AI Analyst Report?
Top Page
Precision System Science Co.,Ltd
(7707)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥194.00
▲(4.30% Upside)
Action:Reiterated
Date:06/04/26
The score is primarily held back by weak financial performance, especially persistent profitability issues and uneven cash-flow quality. Technicals are neutral-to-mixed and do not provide strong support, while valuation is pressured by a high P/E with no dividend yield indicated.
Positive Factors
Market-leading automation focus
The company's core focus on laboratory automation for clinical diagnostics and life-science workflows aligns with a durable trend toward lab efficiency and scaling. Automation products create high switching costs, recurring service and upgrade revenue, and position the firm to capture long-term institutional demand.
Negative Factors
Persistent unprofitability
Negative operating and net margins indicate the business is not converting sales into sustainable profits. Over several quarters this erodes retained earnings and limits capability to self-fund growth or weather demand shocks, forcing reliance on external funding or cost restructuring.
Read all positive and negative factors
Positive Factors
Negative Factors
Market-leading automation focus
The company's core focus on laboratory automation for clinical diagnostics and life-science workflows aligns with a durable trend toward lab efficiency and scaling. Automation products create high switching costs, recurring service and upgrade revenue, and position the firm to capture long-term institutional demand.
Read all positive factors
Precision System Science Co.,Ltd (7707) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.67B
Dividend YieldN/A
Average Volume (3M)159.67K
Price to Earnings (P/E)41.6
Beta (1Y)1.46
Revenue Growth11.29%
EPS GrowthN/A
CountryJP
Employees151
SectorGeneral
Sector StrengthN/A
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)4.93
Shares Outstanding27,666,900
10 Day Avg. Volume171,040
30 Day Avg. Volume159,673
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)1.46
Price to Sales (P/S)1.17
P/FCF Ratio127.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Precision System Science Co.,Ltd Business Overview & Revenue Model
Company Description
Precision System Science Co., Ltd. (PSS), along with its subsidiaries, specializes in the development, production, and global distribution of automated and physicochemical instruments, software, and various related goods, serving both the Japanese...
How the Company Makes Money
null...
Precision System Science Co.,Ltd Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
50
Neutral
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.01B | 4.69B | 3.98B | 5.28B | 7.43B | 9.30B |
| Gross Profit | 1.51B | 1.38B | 950.38M | 1.35B | 2.49B | 3.10B |
| EBITDA | 295.81M | 10.06M | -661.75M | -594.05M | 740.33M | 1.16B |
| Net Income | 134.69M | -253.10M | -1.12B | -1.32B | 45.34M | 795.99M |
Balance Sheet | ||||||
| Total Assets | 5.57B | 4.94B | 6.40B | 9.76B | 11.41B | 11.57B |
| Cash, Cash Equivalents and Short-Term Investments | 942.70M | 1.04B | 1.92B | 2.45B | 2.76B | 4.04B |
| Total Debt | 885.01M | 564.21M | 1.37B | 3.88B | 4.03B | 3.69B |
| Total Liabilities | 1.68B | 1.18B | 2.25B | 4.54B | 4.90B | 4.99B |
| Stockholders Equity | 3.89B | 3.76B | 4.14B | 5.22B | 6.51B | 6.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 43.24M | -130.81M | -162.03M | -1.38B | -2.09B |
| Operating Cash Flow | 0.00 | 95.83M | -106.80M | -6.75M | 869.16M | -280.97M |
| Investing Cash Flow | 0.00 | -8.24M | 2.06B | -213.70M | -2.29B | -1.81B |
| Financing Cash Flow | 0.00 | -910.82M | -2.51B | -154.05M | 93.73M | 4.00B |
Precision System Science Co.,Ltd Technical Analysis
Positive
186.00
Price Trends
205.70
Positive
217.45
Negative
211.47
Negative
Market Momentum
0.56
Negative
54.90
Neutral
77.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7707, the sentiment is Positive. The current price of 186 is below the 20-day moving average (MA) of 206.55, below the 50-day MA of 205.70, and below the 200-day MA of 211.47, indicating a neutral trend. The MACD of 0.56 indicates Negative momentum. The RSI at 54.90 is Neutral, neither overbought nor oversold. The STOCH value of 77.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7707.
Precision System Science Co.,Ltd Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥7.28B | 20.55 | ― | 4.57% | 8.02% | 43.89% | |
58 Neutral | ¥8.71B | 26.47 | ― | ― | 3.66% | 32.11% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
49 Neutral | ¥5.67B | 41.58 | ― | ― | 11.29% | ― | |
45 Neutral | ¥12.82B | -20.35 | ― | ― | -25.02% | -697.06% | |
44 Neutral | ¥5.23B | -5.79 | ― | ― | 246.42% | 9.39% | |
42 Neutral | ¥8.61B | -7.90 | ― | ― | -62.06% | 7.56% |
* General Sector Average
JP:7707
Precision System Science Co.,Ltd
211.00
13.00
6.57%
JP:3386
Cosmo Bio Co., Ltd.
1,244.00
122.66
10.94%
JP:4570
Immuno-Biological Laboratories Co., Ltd.
940.00
434.17
85.83%
JP:4892
Cyfuse Biomedical K.K.
531.00
-125.00
-19.05%
JP:4978
ReproCELL Inc.
132.00
-85.00
-39.17%
JP:7776
CellSeed Inc.
228.00
-249.00
-52.20%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.